AVOQ, LLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to obesity; Issues related to medication affordability and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem